|
Cilostazol
A phosphodiesterase 3 (PDE3) inhibitor
Product Overview
Product Name: Cilostazol
Alternate Name/Synonyms: 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
Description: Cilostazol is a clinically approved phosphodiesterase III (PDE3) inhibitor (IC₅₀ = 0.2 µM) and anti-thrombotic agent. It inhibits platelet aggregation and is a direct arterial vasodilator.
Peptide Sequence: N/A
Appearance: White solid
Formulation: N/A
CAS Number: 73963-72-1
Molecular Formula: C20H27N5O2
Molecular Weight: 369.46
Purity: ≥98% by TLC
Solubility:DMSO (~20 mg/ml)
Storage Temp.: -20 ̊C
Shipping Conditions: gel pack
Handling: Protect from light and air
SMILES: C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
InChi: InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)
InChi Key: RRGUKTPIGVIEKM-UHFFFAOYSA-N
PubChem CID: 2754
MDL Number: MFCD00866780
USAGE: For Research Use Only! Not For Use in Humans. |